Monarch Robotic Bronchoscopy for Lung Nodule ICG Dye Marking Before VATS

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPeking University Cancer Hospital & Institute

About this trial

This is a single-center, prospective, single-arm clinical study conducted at Beijing Cancer Hospital to evaluate the effectiveness, safety, and learning curve of preoperative indocyanine green (ICG) dye marking mixed with iodinated contrast agent under Monarch Robotic Assisted Bronchoscopy (RAB) with Cone-Beam CT (CBCT) for small pulmonary nodules that are difficult to locate during video-assisted thoracic surgery (VATS) sublobectomy. Eligible patients will undergo RAB localization immediately followed by VATS in the same operative session. The primary endpoints include the success rate of localization, effective localization, and VATS sublobar resection. Secondary endpoints include navigation success rate, operation times, reaching depth, complication rates, and health economic outcomes. The learning curve will be analyzed using the cumulative sum (CUSUM) method. A total of 50 patients will be enrolled and followed up for 14 days postoperatively.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18-80 years

Clinically indicated sub-lobar resection

Tolerates general anesthesia

Single/multiple small nodules <20 mm in peripheral lung field

Disqualifiers

Contraindications to bronchoscopy/anesthesia

Coagulopathy or bleeding tendency

Implanted devices interfering with navigation

Allergy to ICG or iodinated contrast

Trial design

Design model

Single group

Treatments tested in this trial

  • Monarch RAB with CBCT-guided ICG Dye Marking

    Procedure/Surgery

    Under general anesthesia, the Monarch RAB platform is used to navigate to the target bronchus. With CBCT confirmation, 0.25 ml of ICG (0.2 mg/ml) mixed with 0.25 ml iodinated contrast is injected within 1 cm of the nodule. The dye marking is identified intraoperatively with near-infrared light to guide VATS sublobectomy.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Experimental: Monarch RAB + CBCT-guided ICG Localization + VATS SublobectomyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Success rate of localization procedure

Calculated as (number of successful localization procedures ÷ total localization procedures) × 100%. Success is defined as ICG dye successfully injected at planned target site as confirmed by CBCT. Unit of Measure: participants (%).

Time frame
Periprocedural( localization procedure)
2

Success rate of effective localization

Calculated as \[(number of successful localization procedures - number unrecognized in operative field) ÷ total localization procedures\] × 100%. Effective localization is defined as visible ICG staining on pleura during VATS. Unit of Measure: participants (%).

Time frame
Perioperative (during VATS)
3

Success rate of VATS sub-lobar resection

Calculated as (number of successful VATS resections ÷ total localization procedures) × 100%. Successful VATS resection is defined as resection containing the complete lesion and the dye together. Unit of Measure: participants (%).

Time frame
Perioperative (during VATS)

Secondary outcomes

1

Learning curve for localization

Number of cases required for surgeon to achieve proficiency using cumulative sum (CUSUM) method based on OT1 and localization success rate.Unit of Measure: case number.

Time frame
Through study completion, up to 8 months
2

Bronchoscopy-related complication rate

Incidence of pneumothorax, bleeding, and respiratory failure related to bronchoscopy, graded according to CTCAE. participants (%).

Time frame
From end of bronchoscopy through Postoperative Day 14.
3

Health economic outcomes

Includes postoperative hospital stay, total hospitalization cost, complication treatment cost, anesthesia cost, and localization procedure cost. Unit of Measure: CNY.

Time frame
During index hospitalization

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: